First City Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Sell
17,988
-515
-3% -$60.3K 1.12% 20
2026
Q1
$2.23M Sell
18,503
-1,050
-5% -$121K 1.18% 19
2025
Q4
$2.06M Sell
19,553
-275
-1% -$25.8K 1.09% 20
2025
Q3
$1.66M Sell
19,828
-1,737
-8% -$143K 0.9% 25
2025
Q2
$1.71M Sell
21,565
-350
-2% -$27.8K 0.99% 23
2025
Q1
$1.97M Sell
21,915
-890
-4% -$83.1K 1.18% 21
2024
Q4
$2.27M Sell
22,805
-1,976
-8% -$204K 1.21% 19
2024
Q3
$2.81M Sell
24,781
-2,101
-8% -$250K 1.45% 15
2024
Q2
$3.33M Sell
26,882
-1,332
-5% -$172K 1.87% 14
2024
Q1
$3.72M Sell
28,214
-1,550
-5% -$191K 2.06% 10
2023
Q4
$3.24M Sell
29,764
-941
-3% -$97.7K 1.88% 10
2023
Q3
$3.16M Sell
30,705
-50
-0.2% -$5.39K 1.98% 10
2023
Q2
$3.55M Sell
30,755
-881
-3% -$100K 2.09% 10
2023
Q1
$3.65M Buy
31,636
+436
+1% +$47.1K 2.14% 8
2022
Q4
$3.46M Sell
31,200
-1,416
-4% -$145K 2.08% 8
2022
Q3
$2.81M Buy
32,616
+1,290
+4% +$115K 1.85% 11
2022
Q2
$2.86M Buy
31,326
+239
+0.8% +$21.2K 1.76% 12
2022
Q1
$2.55M Buy
31,087
+170
+0.5% +$13.4K 1.41% 15
2021
Q4
$2.43M Sell
30,917
-680
-2% -$54.2K 1.37% 17
2021
Q3
$2.37M Buy
31,597
+1,205
+4% +$91.6K 1.34% 20
2021
Q2
$2.31M Buy
30,392
+1,534
+5% +$114K 1.27% 21
2021
Q1
$2.15M Sell
28,858
-128
-0.4% -$9.44K 1.24% 25
2020
Q4
$2.07M Sell
28,986
-23,730
-45% -$1.81M 1.32% 22
2020
Q3
$4.05M Buy
52,716
+23,142
+78% +$1.81M 1.5% 11
2020
Q2
$2.18M Buy
29,574
+1,042
+4% +$78.4K 1.68% 10
2020
Q1
$2.1M Sell
28,532
-1,648
-5% -$130K 2.05% 9
2019
Q4
$2.62M Sell
30,180
-780
-3% -$64.1K 1.8% 7
2019
Q3
$2.49M Sell
30,960
-768
-2% -$61.5K 1.82% 8
2019
Q2
$2.54M Sell
31,728
-235
-0.7% -$18K 1.85% 9
2019
Q1
$2.54M Sell
31,963
-2,061
-6% -$154K 1.82% 10
2018
Q4
$2.48M Sell
34,024
-1,126
-3% -$79.5K 1.93% 7
2018
Q3
$2.38M Sell
35,150
-210
-0.6% -$13.4K 1.58% 10
2018
Q2
$2.05M Sell
35,360
-153
-0.4% -$8.63K 1.46% 13
2018
Q1
$1.85M Buy
35,513
+21
+0.1% +$1.13K 1.38% 18
2017
Q4
$1.91M Buy
35,492
+31
+0.1% +$1.72K 1.3% 21
2017
Q3
$2.17M Sell
35,461
-295
-0.8% -$17.9K 1.52% 13
2017
Q2
$2.19M Sell
35,756
-103
-0.3% -$6.27K 1.59% 12
2017
Q1
$2.17M Sell
35,859
-78
-0.2% -$4.73K 1.6% 12
2016
Q4
$2.02M Sell
35,937
-41
-0.1% -$2.4K 1.52% 13
2016
Q3
$2.14M Sell
35,978
-104
-0.3% -$6.08K 1.64% 12
2016
Q2
$1.98M Sell
36,082
-51
-0.1% -$2.71K 1.5% 15
2016
Q1
$1.82M Sell
36,133
-1,122
-3% -$55K 1.25% 16
2015
Q4
$1.88M Sell
37,255
-104
-0.3% -$5.24K 1.26% 15
2015
Q3
$1.76M Sell
37,359
-830
-2% -$44.1K 1.29% 14
2015
Q2
$2.07M Buy
38,189
+247
+0.7% +$13.9K 1.44% 13
2015
Q1
$2.08M Sell
37,942
-260
-0.7% -$14.7K 1.44% 11
2014
Q4
$2.07M Sell
38,202
-419
-1% -$23.3K 1.43% 11
2014
Q3
$2.18M Sell
38,621
-418
-1% -$23.5K 1.57% 10
2014
Q2
$2.15M Buy
39,039
+294
+0.8% +$16K 1.53% 10
2014
Q1
$2.1M Buy
38,745
+1
+0% +$52 1.5% 11
2013
Q4
$1.85M Sell
38,744
-1,339
-3% -$61.2K 1.52% 11
2013
Q3
$1.82M Buy
40,083
+914
+2% +$41.7K 1.51% 12
2013
Q2
$1.74M Buy
+39,169
New +$1.75M 1.58% 13

Other funds holding MRK

First City Capital Management's MRK Position: Q2 2026 in Review

First City Capital Management reduced its Merck (MRK) stake by 2.8% in Q2 2026, selling an estimated $60.3K and leaving 17,988 shares worth $2.31M. The position accounts for 1.12% of the portfolio, ranked #20.

First City Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.05M in Q3 2020. 652 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • First City Capital Management held 17,988 shares of Merck worth $2.31M as of Q2 2026.
  • First City Capital Management sold 515 Merck shares in Q2 2026, an estimated $60.3K.
  • Merck made up 1.12% of First City Capital Management's portfolio in Q2 2026, its #20 holding.
  • First City Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • First City Capital Management's Merck position peaked at $4.05M in Q3 2020.
  • 652 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on First City Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.